Rutika Mehta, MD, MPH
Hematology & Oncology Physician · New York, NY
Rutika Mehta, MD, MPH is a hematology & oncology physician with a practice address in New York, New York, and NPI 1437443181, issued on May 30, 2011. Check the license (New York 291635, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Rutika Mehta
- Credential
- MD, MPH
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- 291635 NY
ME133135 FL
Self-reported in NPPES; status is on the state search - Practice location
- 1305 York Ave FL 12, New York, NY 10021
- Phone
- (646) 962-6200
- Enumerated
- May 30, 2011
- Record last updated
- Oct 10, 2024
- Medicare enrollment
- Enrolled (PECOS I20250304002679); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 1305 York Ave FL 12
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Alison Borenstein, PA-CPhysician Assistant1982089710
- Paul Chapman, MDMedical Oncology Physician1053354936
- Kyle Godfrey, M.D.Ophthalmic Plastic and Reconstructive Surgery Physician1104268994
- Laurence Gupiteo, AGPCNP-CAdult Health Nurse Practitioner1871482687
- Hilary Heyison, NPFamily Nurse Practitioner1093254229
- Sana Javaid, FNP-BCFamily Nurse Practitioner1104592880
Verify Rutika Mehta in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 291635Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
74% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
230 Medicare Part D claims for 74 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 16% of claims. 49 claims were for opioids.
Most prescribed
- Oxycodone Hcl28 claims
- Pantoprazole Sodium26 claims
- Prochlorperazine Maleate23 claims
- Tramadol Hcl14 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 89.4 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $31,968.98
33 payments; by number, the most common kind was food and beverage; the largest payer was Amgen Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Weill Medical College OF CornellNew York, NY
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Hematology & Oncology Physician providers in New York
There are 1,163 hematology & oncology physician records in New York.
Other hematology & oncology physician records in New York
- Anum Aamir, M.DAstoria, NY1245611052
- Mohammad Maher Abdul Hay, MDNew York, NY1447494729
- Wassim Abida, MD, PHDNew York, NY1518101096
- Mouhamed Yazan Abou-Ismail, M.D.Rochester, NY1336553676
- George Abraham, MDRochester, NY1225552649
- Avram Abramowitz, M.D.Fresh Meadows, NY1407855489
- Ghaith Abu Zeinah, M.D.New York, NY1174962146
- Jose Acostamadiedo, MDPlattsburgh, NY1013910256
- Sylvia Adams, MDNew York, NY1881767903
- Amit Agarwal, M.D.New York, NY1275790826
Common questions
What is Rutika Mehta, MD, MPH's NPI number?
Rutika Mehta, MD, MPH's National Provider Identifier (NPI) is 1437443181, issued on May 30, 2011. An NPI identifies a provider in billing; it is not a license.
Where is Rutika Mehta, MD, MPH located?
The NPPES record lists a practice address at 1305 York Ave FL 12, New York, NY, 10021. Phone: (646) 962-6200. Providers update this record themselves, so call before visiting.
How can I verify Rutika Mehta, MD, MPH's license?
NPPES lists New York license number 291635, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Rutika Mehta, MD, MPH prescribe under Medicare Part D?
In 2024, Rutika Mehta, MD, MPH had 230 Medicare Part D claims for 74 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
What is Rutika Mehta, MD, MPH's MIPS final score?
The 2023 MIPS final score is 89.4 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.